The Hematologist
Ein Podcast von The Hematologist
150 Folgen
-
The End of Transplant for Mantle Cell Lymphoma
Vom: 31.1.2025 -
DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma
Vom: 21.12.2024 -
Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease
Vom: 27.11.2024 -
Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?
Vom: 11.10.2024 -
A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission
Vom: 16.9.2024 -
Anticoagulation Stewardship
Vom: 29.8.2024 -
Blood Global Hematology Editor-in-Chief Shares Vision
Vom: 17.7.2024 -
One on One With Dr. Fred Appelbaum
Vom: 26.6.2024 -
Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms
Vom: 21.6.2024 -
Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives
Vom: 7.5.2024 -
Growing the Next Generation of Hematologists
Vom: 15.4.2024 -
Women in Hematology
Vom: 26.3.2024 -
Four Is Better Than Three: Will We Finally Agree?
Vom: 18.3.2024 -
Toward Equity in Access for ALL
Vom: 30.1.2024 -
The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia
Vom: 29.11.2023 -
Editors-in-Chief of Two New ASH Journals Share Their Visions
Vom: 20.10.2023 -
ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All
Vom: 18.9.2023 -
Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?
Vom: 1.9.2023 -
Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal
Vom: 7.7.2023 -
Drawing New Blood Into Hematology
Vom: 16.6.2023
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
